Background Current vaccines against HPVs are constituted of L1 protein self-assembled into virus-like particles (VLPs) plus they have been proven to protect against organic HPV16 and HPV18 infections and connected lesions. immunized with L1/L2 VLPs, and the best degrees of cross-neutralizing antibodies had been seen in mice immunized with HPV 58 L1/L2 pseudovirions encoding the… Continue reading Background Current vaccines against HPVs are constituted of L1 protein self-assembled